VLDLR and atherosclerosis: β-Carotene supplementation does alter atherosclerosis resolution in β-carotene oxygenase 1-deficient (Bco1-/-) mice infused with antisense oligonucleotide targeting the low-density lipoprotein receptor (ASO-LDLR).